BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23702731)

  • 1. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma.
    Zhou Y; Fan X; Routbort M; Cameron Yin C; Singh R; Bueso-Ramos C; Thomas DA; Milton DR; Medeiros LJ; Lin P
    Mod Pathol; 2013 Oct; 26(10):1338-45. PubMed ID: 23702731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of terminal deoxynucleotidyl transferase expression in T-ALL/LBL accumulates chromosomal abnormalities to induce drug resistance.
    Xiao H; Wang S; Tang Y; Li S; Jiang Y; Yang Y; Zhang Y; Han Y; Wu X; Zheng L; Li Y; Gao Y
    Int J Cancer; 2023 Jun; 152(11):2383-2395. PubMed ID: 36757202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic study of 128 cases of T-lymphoblastic lymphoma/leukemia].
    Yu B; Du JR; Xie JL; Yu R; Zheng XD; Zhu H; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):452-7. PubMed ID: 21055173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia.
    Klairmont MM; Zhou Y; Cheng C; Pui CH; Jeha S; Gruber TA; Liu Y; Inaba H; Choi JK
    Mod Pathol; 2021 Nov; 34(11):2050-2054. PubMed ID: 34148065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
    Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
    J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal deoxynucleotidyl transferase (TdT)-negative T-cell lymphoblastic lymphoma with loss of the T-cell lineage-specific marker CD3 at relapse: a rare entity with an aggressive outcome.
    Hassan M; Abdullah HMA; Wahid A; Qamar MA
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29884716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MIC2 (CD99) as a diagnostic marker for TdT-negative B lymphoblastic lymphoma].
    Ikeda N; Imao T; Hisano Y; Kamao T; Uno M; Mizushima T
    Rinsho Ketsueki; 2023; 64(2):130-132. PubMed ID: 36990733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.
    Terada T
    Int J Clin Exp Pathol; 2012; 5(2):167-70. PubMed ID: 22400079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.
    Morita K; Jain N; Kantarjian H; Takahashi K; Fang H; Konopleva M; El Hussein S; Wang F; Short NJ; Maiti A; Sasaki K; Garcia-Manero G; Konoplev S; Ravandi F; Khoury JD; Jabbour E
    Am J Hematol; 2021 May; 96(5):589-598. PubMed ID: 33639000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
    Jain N; Lamb AV; O'Brien S; Ravandi F; Konopleva M; Jabbour E; Zuo Z; Jorgensen J; Lin P; Pierce S; Thomas D; Rytting M; Borthakur G; Kadia T; Cortes J; Kantarjian HM; Khoury JD
    Blood; 2016 Apr; 127(15):1863-9. PubMed ID: 26747249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of anti-terminal deoxynucleotidyl transferase antibody (TdT) in hematologic pathology].
    Valmary S; Danjoux M; Delsol G; Brousset P
    Ann Pathol; 2005 Feb; 25(1):25-32. PubMed ID: 15981929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Outcome of 126 adolescent and adult T-cell acute leukemia/lymphoma patients and the prognostic significance of early T-cell precursor leukemia subtype].
    Liao HY; Sun ZY; Wang YX; Jin YM; Zhu HL; Jiang NG
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):561-567. PubMed ID: 32397018
    [No Abstract]   [Full Text] [Related]  

  • 14. Early T-Cell Precursor Leukemia: A High-Risk Subtype of Acute Lymphoblastic Leukemia, Single Center Experience in Jordan.
    Halahleh K; Muradi I; Khalil MZ; Halahleh L; Sughayer M; Kamal N; Sultan I; Alrabi K
    Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e411-e419. PubMed ID: 37730482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal Deoxynucleotidyl Transferase (TdT)-negative Lymphoblastic Leukemia in Pediatric Patients: Incidence and Clinical Significance.
    Yasmeen S; Rajkumar A; Grossman H; Szallasi A
    Pediatr Dev Pathol; 2017; 20(6):463-468. PubMed ID: 29187045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.
    Faber J; Kantarjian H; Roberts MW; Keating M; Freireich E; Albitar M
    Arch Pathol Lab Med; 2000 Jan; 124(1):92-7. PubMed ID: 10629138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of TdT expression in acute myeloid leukemia with an intermediate-risk karyotype.
    Saburi M; Ogata M; Satou T; Soga Y; Itani K; Kohno K; Kondo Y; Nakayama T
    Int J Hematol; 2020 Jul; 112(1):17-23. PubMed ID: 32253665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
    Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
    Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.